After its top vaccine official left the Food and Drug Administration (FDA), the agency announced Tuesday that it has named his replacement.
In an April 1 statement on X, the FDA said Scott Steele would be the acting head of the Center for Biologics Evaluation and Research (CBER), which Peter Marks once led.
“Dr. Steele is a science, technology, and policy professional at FDA with extensive experience in multiple disciplines, including emerging science and technology, translational science, public health preparedness, and biodefense and medical countermeasures,” the FDA statement said.
Since 2017, Steele has had multiple roles in the FDA and, most recently, was a senior adviser to CBER’s translational science office, according to the FDA. Before that, he worked on an assignment in the FDA’s Center for Drug Evaluation and Research on policies....
